Revenue
$1.4M
▼ 94.5% YoY
Net Income
-$19.9M
▲ 31.2% YoY
EPS
$-17.16
▲ 57.1% YoY
Cash
$2.2M
▼ 67.8% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Rose Keith Dale Chief Medical Officer | Grant | May 1, 2026 | 15.0K | $0.00 | $0 | Form 4 ↗ |
Sigsbee William Mark | Grant | Mar 25, 2026 | 11.5K | $0.00 | $0 | Form 4 ↗ |
Rozenbaum Moshe H | Grant | Mar 25, 2026 | 11.5K | $0.00 | $0 | Form 4 ↗ |
Reznick Yehuda | Grant | Mar 25, 2026 | 7.7K | $0.00 | $0 | Form 4 ↗ |
KIDRON NADAV | Grant | Mar 25, 2026 | 7.7K | $0.00 | $0 | Form 4 ↗ |
Kidron Miriam | Grant | Mar 25, 2026 | 7.7K | $0.00 | $0 | Form 4 ↗ |